Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Will have a look. Thanks
Ouch. Germany study says there is no proven benefit. https://medicalxpress.com/news/2023-07-widely-blood-purifier-proven-benefit.html
Ouch. Also getting hit with these class actions being filed on false advertising.
https://seekingalpha.com/news/3925854-celsius-holdings-pay-rapper-flo-rida-826m-for-breached-contract
Finally hit SA after the close
Earnings out
CytoSorbents Reports Fourth Quarter and Full Year 2021 Results and Provides 2022 Outlook https://seekingalpha.com/pr/18701937-cytosorbents-reports-fourth-quarter-and-full-year-2021-results-and-provides-2022-outlook?source=copyToPasteboard
n addition, as more fully described in the linked PDF, in connection with the preparation of its 2021, the Company determined that the calculation and expense of non-cash share-based compensation, related to grants of stock options and restricted stock units awarded to certain former employees and retired directors were materially understated for the three and six month periods ended June 30, 2021 and three and nine month periods ended September 30, 2021 and did not comply with U.S. GAAP. In order to correct previously reported non-cash share-based compensation during these periods, the Company is recognizing additional non-cash share-based compensation expense of approximately $3,180,000 for the three month period ended June 30, 2021 and approximately $12,116,000 for the three month period ended September 30, 2021. The recognition of additional non-cash share-based compensation expense does not impact the Company's cash, revenue, other aspects of its operations or its business fundamentals.
The Company's management has concluded, however, that as a result of the above identified errors, a material weakness exists in the Company's internal controls over financial reporting related to the misapplication of U.S. GAAP in the Company's evaluation of modifications to share based payment arrangements and that the Company's disclosure controls and procedures were not effective as of December 31, 2021. The Company has taken remedial actions in this regard.
Earnings out
Celsius Holdings, Inc. Reports Record Preliminary and Unaudited Fourth Quarter and Full Year 2021 Financial Results https://seekingalpha.com/pr/18692271-celsius-holdings-inc-reports-record-preliminary-and-unaudited-fourth-quarter-and-full-year?source=copyToPasteboard
Celsius: Don't Copy The Insiders https://seekingalpha.com/article/4479660-celsius-dont-copy-insiders?
Monster Beverage is said to explore deal with Constellation Brands (update) https://seekingalpha.com/news/3773103-monster-beverage-is-said-to-explore-deal-with-constellation-brands?source=copyToPasteboard
FYI. exthera medical is promoting
iAnthus to consider appeal after Ontario Court ruling https://seekingalpha.com/news/3752566-ianthus-to-consider-appeal-after-ontario-court-ruling?source=copyToPasteboard
Celsius Holdings Is Going Full On Mainstream - What It Means For The Stock https://seekingalpha.com/article/4454338-celsius-holdings-going-full-on-mainstream?source=copyToPasteboard
Glad I got out.
Innovative Food Holdings, Inc. Reports Financial Results for Second Quarter and First Half of 2021 https://seekingalpha.com/pr/18447240-innovative-food-holdings-inc-reports-financial-results-for-second-quarter-and-first-half-of?source=copyToPasteboard
PR Newswire
BOCA RATON, Fla., Aug. 12, 2021 /PRNewswire/ -- Celsius Holdings, Inc., (CELH) (Nasdaq: CELH), maker of the leading global fitness drink, CELSIUS®, today reported financial results for the second quarter ended June 30, 2021. Management will host a conference call today at 10:00 a.m. Eastern Time to discuss the results with the investment community.
https://mma.prnewswire.com/media/543352/Celsius_Holdings_Logo.jpg
A PDF containing our second quarter 2021 results and full financial tables is available at: www.celsiusholdingsinc.com/Q2_2021
To participate in the conference call, please call one of the following telephone numbers at least 10 minutes before the start of the call:
US: 877-709-8150
International: 201-689-8354
An audio replay of the call will be available on the Company's website at:
https://www.celsiusholdingsinc.com/press-releases/
CytoSorbents stock jumps 18% on second FDA Breakthrough Device tag for DrugSorb-ATR system https://seekingalpha.com/news/3729470-cytosorbents-stock-jumps-18-on-second-fda-breakthrough-device-tag-for-drugsorb-atr-system?source=copyToPasteboard
Interesting: Where Food Comes From declares $0.15 special dividend https://seekingalpha.com/news/3711762-where-food-comes-from-declares-0_15-special-dividend
I guess it’s not needed for any planned acquisitions.
Techxen just posted he has started reallocating into other opportunities.
Celsius: Fairly Valued With A Measurable Competitive Advantage https://seekingalpha.com/article/4436054-celsius-fairly-valued-with-competitive-advantage
No I haven’t. I don’t want to cry wolf. Maybe someone can ask Techxen for us.
Celsius Holdings Announces Proposed Public Offering of Common Stock https://seekingalpha.com/pr/18352651-celsius-holdings-announces-proposed-public-offering-of-common-stock
Earnings out. Another loss. Not even worth talking about.
Interesting. They seemed to go above and beyond the study to express some negative thoughts on the filter.